期刊文献+

含左氧氟沙星序贯疗法对幽门螺杆菌感染补救治疗的疗效分析 被引量:3

Levofloxacin- containing Sequential Therapy for Helicobacter Pylori Infection:Efficacy of Remedial Therapy
下载PDF
导出
摘要 目的比较由埃索美拉唑、左氧氟沙星、阿莫西林、呋喃唑酮、丽珠得乐组成的10日序贯疗法与标准的10日四联疗法对幽门螺杆菌(H.pylori,Hp)感染补救治疗的疗效及安全性。方法将72例初次根除治疗失败的幽门螺杆菌阳性患者,随机分为两组。治疗组前5日应用埃索美拉唑20mg加左氧氟沙星200mg及阿莫西林1000mg,每日2次口服,后5日用埃索美拉唑20mg加左氧氟沙星200mg、呋喃唑酮100mg及丽珠得乐220mg,每日2次口服;对照组采用10d埃索美拉唑20mg,呋喃唑酮100mg,四环素750mg,丽珠得乐220mg,每日2次口服。观察服药期间患者不良反应的发生例数和症状缓解情况,停药4周后复查幽门螺杆菌。结果治疗组幽门螺杆菌根除率91.9%,对照组82.8%,差异有统计学意义(P<0.05);不良反应发生率分别为10.8%和22.9%,差异有统计学意义(P<0.05)。结论由埃索美拉唑、左氧氟沙星、阿莫西林、呋喃唑酮、丽珠得乐组成的10日序贯疗法治疗成人幽门螺杆菌感染具有疗效高、安全性好等优点。 Objective To evaluate whether lO-day sequential therapy including esomeprazole,levofloxacinand,amoxicillin,amoxicillin, furazolidone and Lizhu Dele remedial therapy in Helicobacter pylori infection is better than 10-day standard quadruple therapy and the risk of adverse events between these two regimens. Methods Seventy-two Helicobaeter pylori-positive patients with treatment failure of initial eradication were randomly divided into two groups:treatment group and control group, and the treatment group (37 patients)was treated with esomeprazole 20mg,levofloxacinand 200mg,amoxicillin 1000mg at first five days,orally two times a day at first five days and esomeprazole 20mg,levofloxacin 200mg,furazolidone 100mg and Lizhu Dele 220mg,orally two times a day at the second five days. The control group (35 patients)was treated with esomeprazole 20mg,levofloxacinand 200mg,furazolidone 100mg and tetracycline 750rag,orally two times a day for ten days. The incidence of adverse events during the medication was observed and Helicobacter pylori was detected 4 weeks after discontinuation. Results The eradication rate of the lO-day sequential therapy was 91.9% and that of the control group was 82.8% ,with a significant difference between the two groups (P〈0.05). The incidence rat of adverse events of the 10-day sequential therapy was 10.8% and that of the control group was 22.9% ,with a significant difference between the two groups (P〈0.05). Conclusion The sequential therapy in the composition of esomeprazole,levofloxacinand,amoxicillin,amoxicillin,furazohdone and Lizhu Dele is safe and more effective compared with standard quadruple therapy for re-eradicating Helicobacter pylori infection.
出处 《中国现代医生》 2010年第30期114-116,共3页 China Modern Doctor
关键词 序贯疗法 幽门螺杆菌 左氧氟沙星 根除率 Sequential therapy Helicobacter pylori Levofloxacinand Remedial therapy
  • 相关文献

参考文献13

  • 1Malfertheinerp,Treiber G. What constitutas failure for Helicobacter pylori eradication therapy[J]. Can J Gastroenterol, 2003,17(Suppl B ) : s53-s57.
  • 2成虹,胡伏莲.第三次全国幽门螺杆菌共识会议[J].中华消化杂志,2007,27(11):744-744. 被引量:24
  • 3Mukhopadhyay AK, Kersulyte D,Jeong JY, et al. Distinctiveness of genotypes of Helicobacter pylori in Calcutta,India[J]. J Bacteriol,2000,182: 3219.
  • 4Moder KA,Layer F,Konig W,et al. Rapid screening of clarithromycin resistance in Hehcobacter pylori by pyrosequencing[J]. J Med Microbiol, 2007,56(10) : 1370-1376.
  • 5Cheon JH,Kim N,Lee DH,et al. Trial of moxifloxacin-containing triple Therapy after initial and second-hne treatment failures for helicobacter pylori infection[J]. Korean J Gastroenterol, 2005,45 (2) : 111.
  • 6Di Cam S,Franceschi F,Mariani A,et al. Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication[J]. Dig Liver Dis, 2009,41 (7) :480-485.
  • 7Zullo A,Gatta L,De Francesco V,et al. High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with pepticulcer:a prospective controlled study [J]. Aliment Pharmacol Ther, 2005,21(12) : 1419-1424.
  • 8Vaira D,Zullo A,VakilN,et al. Sequential therapy versus standard triple drug therapy for Helieobacter pylori eradication:a randomized trial [J]. Arm InternMed, 2007,146(8) : 556-563.
  • 9Miner P Jr,Katz PO,Chen Y,Sostek M, Gastric acid control with esomeprazolc, lansoprazole, omeprazole, pantoprazole, and rabeprazole : five-way crossover study [J]. Am J Gastroenterol,2003,98 (12): 2616-2620.
  • 10Gatta L,Zullo A,Perna F,et al. A 10-day levofloxacin-based triple therapy in patients who have faoled two eradication courses[J]. Aliment Pharmacol Ther,2005,22( 1 ) :45-49.

共引文献23

同被引文献42

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部